Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Peralta Cancer Research Institute (PCRI) was a pioneering non-profit research organization located in Oakland, California, that was highly influential during the 1970s and 1980s. The institute was globally recognized for its foundational work in breast cancer biology, specifically the development of techniques to isolate and culture human mammary epithelial cells (HMEC) from primary tissue. Under the leadership of prominent scientists like Dr. Adeline Hackett and Dr. Helene Smith, PCRI established critical cell line models that allowed for the study of carcinogenesis in human tissue rather than animal models. The institute's research laid the groundwork for modern molecular studies of breast cancer progression and genomic instability. Following institutional mergers, its research legacy was largely integrated into the California Pacific Medical Center (CPMC) and the broader Sutter Health network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peralta Cancer Research Institute.